Skip to main content

Advertisement

Log in

Microcystic Adnexal Carcinoma and a Summary of Other Rare Malignant Adnexal Tumours

  • Skin Cancer (SZ Aasi, Section Editor)
  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

Microcystic adnexal carcinoma (MAC) is a rare, slow-growing, infiltrative malignant tumour most commonly found on the head and neck. It often presents as a solitary skin-coloured or yellow papule, plaque or nodule. Ultraviolet radiation, immunosuppression and ionising radiation are possible risk factors. Clinical and histological differential diagnoses include morpheaform basal cell carcinoma and desmoplastic trichoepithelioma. The diagnosis is usually made by skin biopsy, and the characteristic features are small keratin-filled cysts with nests and cords which resemble ductal structures. Immunohistochemistry can assist in differentiating MAC from other tumours. The local aggressive nature of the tumour and its potential to infiltrate beyond the assessed clinical margins warrant complete excision with margin control, and we recommend Mohs micrographic surgery. Wide local excision is widely performed but is associated with recurrence given its infiltrative nature and extensive subclinical extension. The role of radiotherapy in the management of MAC is unclear.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Goldstein DJ, Barr RJ, Santa Cruz DJ. Microcystic adnexal carcinoma: a distinct clinicopathologic entity. Cancer. 1982;50:566.

    Article  CAS  PubMed  Google Scholar 

  2. Lipper S, Peiper SC. Sweat gland carcinoma with syringomatous features: a light microscopic and ultrastructural study. Cancer. 1979;44:157–63.

    Article  CAS  PubMed  Google Scholar 

  3. Cooper PH, Mills SE. Microcystic adnexal carcinoma. J Am Acad Dermatol. 1984;10:908–14.

    Article  CAS  PubMed  Google Scholar 

  4. Cooper PH, Mills SE, Leonard DD, Santa Cruz DJ, Headington JT, Barr RJ, et al. Sclerosing sweat duct (syringomatous) carcinoma. Am J Surg Pathol. 1985;9:422–33.

    Article  CAS  PubMed  Google Scholar 

  5. Cooper PH. Sclerosing carcinomas of sweat ducts (microcystic adnexal carcinoma). Arch Dermatol. 1986;122:261–4.

    Article  CAS  PubMed  Google Scholar 

  6. Santa Cruz DJ. Sweat gland carcinomas: a comprehensive review. Semin Diagn Pathol. 1987;4:38–74.

    Google Scholar 

  7. Requena L, Marquina A, Alegre V, Aliaga A, Sanchez Yus E. Sclerosing (microcystic adnexal) carcinoma: a tumour from a single eccrine origin. Clin Exp Dermatol. 1990;15:222–4.

    Article  CAS  PubMed  Google Scholar 

  8. Sebastien TS, Nelson BR, Lowe L, Baker S, Johnson TM. Microcystic adnexal carcinoma. J Am Acad Dermatol. 1993;29:840–5.

    Article  CAS  PubMed  Google Scholar 

  9. Yu JB, Blitzbau RC, Patel SC, et al. Surveillance, Epidemiology and End Results (SEER) database analysis of microcystic adnexal carcinoma (sclerosing sweat duct carcinoma) of the skin. Am J Clin Oncol. 2010;33:125.

    Article  PubMed  Google Scholar 

  10. Caroll P, Goldstein GD, Brown CW Jr. Metastatic microcystic adnexal carcinoma in an immunocompromised patient. Dermatol Surg. 2000;26:531.

    Article  Google Scholar 

  11. Snow S, Madjar DD, Hardy S, et al. Microcystic adnexal carcinoma: report of 13 cases and review of the literature. Dermatol Surg. 2001;27:401.

    CAS  PubMed  Google Scholar 

  12. Schwarze HP, Loche F, Lamant L, et al. Microcystic adnexal carcinoma induced by multiple radiation therapy. Int J Dermatol. 2000;39:369.

    Article  CAS  PubMed  Google Scholar 

  13. McAlvany JP, Stonecipher MR, Leshin B, et al. Sclerosing sweat duct carcinoma in an 11-year-old boy. J Dermatol Surg Oncol. 1994;20:767.

    Article  CAS  PubMed  Google Scholar 

  14. Ps N, Bourgeois KM, Nicotri T Jr, et al. Sclerosing sweat duct carcinoma in a 6-year-old African American child. Paediatr Dermatol. 2008;25:38.

    Article  Google Scholar 

  15. Smart DR, Taintor AR, Kelly ME, et al. Microcystic adnexal carcinoma: the first reported congenital case. Paeditr Dermatol. 2011;28:35.

    Article  Google Scholar 

  16. Fu T, Clark FL, Lorenz HP, Bruckner AL. Congenital microcystic adnexal carcinoma. Arch Dermatol. 2011;28:35.

    Google Scholar 

  17. Hamed NS, Khachemoune A. Microcystic adnexal carcinoma: a focused review and updates. J Dermatol Dermatologic Surg. 2015;19:20–5.

    Article  Google Scholar 

  18. • Chaudhari BA, Blanchard L, Chaudhari PJ, Lythgoe T. The first reported case of metastatic microcystic adnexal carcinoma in an adolescent. Dermatol Surg. 2015;41:286–8. This is the first ever case report in the literature of metastatic microcystic adnexal carcinoma in an adolescent

    Article  CAS  PubMed  Google Scholar 

  19. Leibovitch I, Huilgol SC, Selva D, et al. Microcystic adnexal carcinoma: treatment with Mohs micrographic surgery. J Am Acad Dermatol. 2005;52:295.

    Article  PubMed  Google Scholar 

  20. Sellheyer K, Nelson P, Kutzner H, Patel RM. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers. J Cutan Pathol. 2013;40:363–70.

    Article  PubMed  Google Scholar 

  21. Krahl D, Sellheyer K. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma. J Cutan Pathol. 2007;34:782–7.

    Article  PubMed  Google Scholar 

  22. Sellheyer K, Krahl D. PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoiec basal cell carcinoma and desmoplastic trichoepithelioma. Br J Dermatol. 2011;164:141–7.

    Article  CAS  PubMed  Google Scholar 

  23. • Giambrone D, Salvaggio C, Victor FC, Rao BK. Microcystic adnexal carcinoma detected by reflectance confocal microscopy. Dermatol Surg. 2016;42:126–7. This letter of correspondence is the first case in which reflectance confocal microscopy has been used to detect microcystic adnexal carcinoma

    Article  CAS  PubMed  Google Scholar 

  24. • Alawi SA, Batz S, Rowert-Huber J, Fluhr JW, et al. Correlation of optical coherence tomography and histology in microcystic adnexal carcinoma: a case report. Skin Res Technol. 2015;21:15–7. This is the first case report of optical coherence tomography criteria for microcystic adnexal carcinoma correlated with conventional histopathology

    Article  CAS  PubMed  Google Scholar 

  25. Salerno S, Terrill P. Will MAC be back? ANJ J Surg. 2003;73:830–2.

    Google Scholar 

  26. Leboit PE, Sexton M. Microcystic adnexal carcinoma of the skin. J Am Acad Dermatol. 1993;29:609–18.

    Article  CAS  PubMed  Google Scholar 

  27. Burns MK, Chen SP, Goldberg LH. Microcystic adnexal carcinoma. Ten cases treated by Mohs micrographic surgery. J Dermatol Surg Oncol. 1994;20:429–34.

    Article  CAS  PubMed  Google Scholar 

  28. Friedman PM, Friedman RH, Jiang B, Nouri K, Amonette R, Robins P. Microcystic adnexal carcinoma: collaborative series review and update. J Am Acad Dermatol. 1999;41:225–31.

    Article  CAS  PubMed  Google Scholar 

  29. Abbate M, Zeitouni N, Seyler M, Hicks W, Loree T, Cheney RT. Clinical course, risk factors and treatment of microcystic adnexal carcinoma: a short series report. Dermatol Surg. 2003;29:1035–8.

    PubMed  Google Scholar 

  30. Leibovitch I, Huilgol SC, Richards S, Paver R, Selva D. Periocular microcystic adnexal carcinoma: management and outcome with Mohs micrographic surgery. Opthalmologica. 2006;220:109–13.

    Article  Google Scholar 

  31. Wetter R, Goldstein GD. Microcystic adnexal carcinoma: a diagnostic and therapeutic challenge. Dermatol Ther. 2008;21:452.

    Article  PubMed  Google Scholar 

  32. Baxi S, Deb S, Weedon D, Baumann K, Poulsen M. Microcystic adnexal carcinoma of the skin: the role of adjuvant radiotherapy. J Med Imag and Rad Oncol. 2010;54:477–82.

    Article  Google Scholar 

  33. •• Mestre T, Oliphant T, Lawrence CM, Barnes E, Clarke L, Dickinson J, et al. Mohs micrographic surgery is the required treatment for periocular microcystic adnexal carcinoma to maximise the possibility of tumour clearance. Br J Dermatol. 2016;175(S1):119. This 10-year case series review demonstrates the high incidence of perineural invasion in periocular microcystic adnexal carcinoma and advocates the use of Mohs micrographic surgery at this high-risk site

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arif Aslam MBChB, MRCP.

Ethics declarations

Conflict of Interest

The author declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Skin Cancer

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aslam, A. Microcystic Adnexal Carcinoma and a Summary of Other Rare Malignant Adnexal Tumours. Curr. Treat. Options in Oncol. 18, 49 (2017). https://doi.org/10.1007/s11864-017-0491-z

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11864-017-0491-z

Keywords

Navigation